Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis.

Lars Christian LundMikkel HøjlundDaniel Pilsgaard HenriksenNina Sahlertz KristiansenKasper Bruun Kristensen

Published in: Pharmacoepidemiology and drug safety (2021)

Initiation of SGLT2-Is was associated with a markedly decreased risk of gout compared to initiation of GLP1-RAs. The findings are comparable to prior studies addressing this association.

Keyphrases

uric acid
metabolic syndrome
case control